Not an SEC registrant

McKesson Drug Co.

Customers

None disclosed

Suppliers

1 disclosed

Latest period

Dec 31, 2025

10-K filed 2026-02-27

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose McKesson Drug Co. as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from McKesson Drug Co.	Period	Trend	Status	Source
AMRX Amneal Pharmaceuticals, Inc.	Named	—	FY 2025-12-31	—	Active	10-K 2026-02-27
Our four largest customers, Cencora, Inc., McKesson Drug Co., Cardinal Health, Inc. and CVS Health Corporation, accounted for approximately 71%, 70% and 70% of total net sales of products for the years ended December 31, 2025, 2024 and 2023, respectively. 10-K filed 2026-02-27 Period FY 2025-01-01 to 2025-12-31Accession 0001723128-26-000011

Alerts are coming

Get an email when McKesson Drug Co.'s disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.